Schonfeld Strategic Advisors LLC Omeros Corp Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $173,040 - $417,760	-56,000 Reduced 40.55%	82,100 $258,000
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $192,768 - $630,512	100,400 Added 266.31%	138,100 $380,000
Q1 2022 May 16, 2022	BUY	$5.07 - $7.2 $88,218 - $125,280	17,400 Added 85.71%	37,700 $227,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $29,019 - $43,707	5,118 Added 33.71%	20,300 $131,000
Q3 2021 Nov 16, 2021	SELL	$13.4 - $16.3 $61,747 - $75,110	-4,608 Reduced 23.28%	15,182 $209,000
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $126,966 - $164,001	8,573 Added 76.43%	19,790 $293,000
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $162,870 - $263,936	11,217 New	11,217 $200,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.